Primary Epithelioid Sarcoma of Bone

Cheng, 2008, Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior, Mod Pathol, 21, 647, 10.1038/modpathol.2008.44

Enzinger, 1970, Epithelioid sarcoma: a sarcoma simulating a granuloma or a carcinoma, Cancer, 26, 1029, 10.1002/1097-0142(197011)26:5<1029::AID-CNCR2820260510>3.0.CO;2-R

Fletcher, 1991, Epithelioid angiosarcoma of deep soft tissue: a distinctive tumor readily mistaken for an epithelial neoplasm, Am J Surg Pathol, 15, 915, 10.1097/00000478-199110000-00001

Fletcher, 2002, Pathology and Genetics of Tumours of Soft Tissue and Bone

Gray, 1990, Cytokeratin expression in epithelioid vascular neoplasms, Hum Pathol, 21, 212, 10.1016/0046-8177(90)90131-N

Guillou, 1997, “Proximal-type” epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series, Am J Surg Pathol, 21, 130, 10.1097/00000478-199702000-00002

Gunduz, 1998, Malignant rhabdoid tumor of the orbit, Arch Ophthalmol, 116, 243, 10.1001/archopht.116.2.243

Hasegawa, 1993, Osteosarcoma with epithelioid features. An immunohistochemical study, Arch Pathol Lab Med, 117, 295

Izumi, 2006, Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor, Mod Pathol, 19, 820, 10.1038/modpathol.3800599

Judkins, 2007, Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology, Adv Anat Pathol, 14, 335, 10.1097/PAP.0b013e3180ca8b08

Kohashi, 2007, Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR, J Cancer Res Clin Oncol, 133, 817, 10.1007/s00432-007-0223-z

Kohashi, 2009, Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor, Hum Pathol, 40, 349, 10.1016/j.humpath.2008.08.007

Laskin, 2003, Epithelioid sarcoma: new insights based on an extended immunohistochemical analysis, Arch Pathol Lab Med, 127, 1161, 10.5858/2003-127-1161-ESNIBO

Medjkane, 2004, The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization, Cancer Res, 64, 3406, 10.1158/0008-5472.CAN-03-3004

Miettinen, 1999, Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis, Hum Pathol, 30, 934, 10.1016/S0046-8177(99)90247-2

Modena, 2005, SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas, Cancer Res, 65, 4012, 10.1158/0008-5472.CAN-04-3050

Muchardt, 2001, When the SWI/SNF complex remodels the cell cycle, Oncogene, 20, 3067, 10.1038/sj.onc.1204331

Oda, 2006, Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features, Pathol Int, 56, 287, 10.1111/j.1440-1827.2006.01962.x

Perry, 2005, INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas, Mod Pathol, 18, 951, 10.1038/modpathol.3800375

Robbens, 2007, An extrarenal rhabdoid tumor of the cervical spine with bony involvement, Skeletal Radiol, 36, 341, 10.1007/s00256-006-0104-6

Sigauke, 2006, Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis, Mod Pathol, 19, 717, 10.1038/modpathol.3800581

van de Rijn, 1994, CD34: a review, Appl Immunohistochem, 2, 71

Versteege, 2002, A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle, Oncogene, 21, 6403, 10.1038/sj.onc.1205841

Weiss, 2008, Enzinger and Weiss' Soft Tissue Tumors. 5th ed